• 1. Ester-mediated peptide formation promoted by deep eutectic solvents: a facile pathway to proto-peptides?
  Chen-Yu Chien,Sheng-Sheng Yu Chem. Commun., 2020,56, 11949-11952
• 2. Examination of the hydrogen-bonding networks in small water clusters (n = 2–5, 13, 17) using absolutely localized molecular orbital energy decomposition analysis?
  Erika A. Cobar,Paul R. Horn,Robert G. Bergman,Martin Head-Gordon Phys. Chem. Chem. Phys., 2012,14, 15328-15339
• 3. Enabling chloride salts for thermal energy storage: implications of salt purity?
  J. Matthew Kurley,Phillip W. Halstenberg,Abbey McAlister,Stephen Raiman,Richard T. Mayes RSC Adv., 2019,9, 25602-25608
• 4. Excimer emission and magnetoluminescence of radical-based zinc(ii) complexes doped in host crystals?
  Shojiro Kimura,Tetsuro Kusamoto Chem. Commun., 2020,56, 11195-11198
• 5. Excimer formation effects and trap-assisted charge recombination loss channels in organic solar cells of perylene diimide dimer acceptors?
  Min Kim,Jae-Joon Lee,Tengling Ye,Panagiotis E. Keivanidis,Kilwon Cho J. Mater. Chem. C, 2020,8, 1686-1696

• Solvents and Organic Chemicals Organic Compounds Organohalogen compounds Vinyl halides Vinyl fluorides

Professional Introduction to Polyperfluoroethoxymethoxy Difluoroethyl PEG Ether (CAS No. 162492-15-1)

Polyperfluoroethoxymethoxy Difluoroethyl PEG Ether, identified by the Chemical Abstracts Service Number (CAS No.) 162492-15-1, is a specialized fluorinated ether compound that has garnered significant attention in the field of pharmaceuticals and materials science due to its unique chemical properties and versatile applications. This compound belongs to the class of polyethylene glycol (PEG)-based derivatives, which are widely recognized for their solubilizing, stabilizing, and lubricating capabilities. The presence of both perfluoro and difluoro functional groups in its molecular structure imparts exceptional thermal stability, low surface tension, and high lipophilicity, making it an invaluable asset in various industrial and scientific domains.

The molecular architecture of Polyperfluoroethoxymethoxy Difluoroethyl PEG Ether consists of a PEG backbone substituted with perfluoroethoxy and difluoroethyl groups. This configuration not only enhances its solubility in both polar and non-polar solvents but also allows for fine-tuning its physicochemical properties to suit specific applications. The fluorine atoms contribute to the compound's resistance to hydrolysis and oxidation, ensuring prolonged shelf life and consistent performance under harsh conditions.

In recent years, advancements in drug delivery systems have highlighted the potential of fluorinated PEG ethers as carriers for bioactive molecules. The lipophilic nature of this compound makes it an excellent candidate for formulating oral and transdermal medications, where poor solubility is a major challenge. By incorporating Polyperfluoroethoxymethoxy Difluoroethyl PEG Ether into drug formulations, researchers have observed improved bioavailability and reduced degradation rates of therapeutic agents. This has been particularly beneficial in the development of anti-cancer drugs, where targeted delivery systems can enhance treatment efficacy while minimizing side effects.

The pharmaceutical industry has also explored the use of this compound in the synthesis of novel biomaterials. Its ability to form stable complexes with proteins and peptides has opened new avenues for creating biocompatible coatings for medical implants. For instance, studies have demonstrated that coatings derived from Polyperfluoroethoxymethoxy Difluoroethyl PEG Ether can significantly reduce biofilm formation on catheters and artificial joints, thereby preventing infections and improving patient outcomes.

Beyond pharmaceutical applications, this fluorinated ether has found utility in advanced material science. Its low surface tension and thermal stability make it an ideal candidate for surface modification techniques, such as plasma treatment and anti-fouling coatings. Researchers have leveraged its properties to develop ultra-low friction surfaces for microfluidic devices, which are critical in diagnostic assays and lab-on-a-chip technologies. The compound's resistance to chemical attack further enhances its suitability for high-performance materials used in aerospace and automotive industries.

Recent studies have also delved into the environmental impact of fluorinated compounds, including Polyperfluoroethoxymethoxy Difluoroethyl PEG Ether. While fluorinated chemicals are often associated with environmental persistence, efforts have been made to develop greener synthetic routes that minimize waste generation and energy consumption. Innovations in catalytic processes have enabled more efficient production methods, reducing the ecological footprint of these valuable compounds. Furthermore, research is ongoing to assess their biodegradability under controlled conditions, ensuring that their benefits can be harnessed without compromising ecological balance.

The role of Polyperfluoroethoxymethoxy Difluoroethyl PEG Ether in nanotechnology is another emerging field of interest. Its ability to stabilize nanoparticles during synthesis has led to breakthroughs in drug delivery systems based on liposomes and polymeric micelles. These nanoformulations offer precise control over drug release profiles, enabling sustained therapeutic action with reduced dosing frequency. The compound's compatibility with various hydrophobic drugs has made it a preferred choice for encapsulating molecules that would otherwise exhibit poor water solubility.

In conclusion, Polyperfluoroethoxymethoxy Difluoroethyl PEG Ether (CAS No. 162492-15-1) represents a cutting-edge material with broad applicability across multiple scientific disciplines. Its unique combination of chemical properties makes it indispensable in pharmaceutical development, material science, and nanotechnology. As research continues to uncover new uses for this compound, its significance is expected to grow further, driving innovation in both academic research and industrial applications.

• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)